UPL574.05

UPL Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersPIINDSUMICHEMRALLISCOROMANDELSRFSOLARINDSPIDILITINDBASFMcap ₹48,507 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations10,170.09,887.014,078.09,067.011,090.010,907.015,573.09,216.012,019.012,269.018,335.010,181.0
Other Income105.0151.0126.098.0111.0170.0107.0143.0250.092.0178.0217.0
Total Income10,275.010,038.014,204.09,165.011,201.011,077.015,680.09,359.012,269.012,361.018,513.010,398.0
Expenses
+ Cost of Materials Consumed5,232.06,323.09,009.04,520.05,823.05,329.08,551.04,961.06,136.06,362.06,469.05,621.0
+ Purchases of Stock-in-Trade0.00.00.00.00.00.00.01,414.0709.01,117.0568.01,472.0
+ Changes in Inventories0.00.00.00.00.00.00.0-2,206.0-1,092.0-1,633.03,086.0-2,778.0
+ Employee Benefit Expense1,251.01,155.01,036.01,337.01,337.01,184.01,451.01,322.01,466.01,379.01,640.01,527.0
+ Finance Costs871.01,191.01,090.0913.01,070.0730.0914.01,007.0784.0774.0836.0852.0
+ Depreciation & Amortisation657.0676.0794.0660.0697.0688.0705.0731.0771.0827.0915.0832.0
+ Other Expenses2,362.02,316.02,185.02,109.02,578.02,438.02,380.02,329.02,799.02,727.03,014.02,889.0
Total Expenses10,373.011,661.014,114.09,539.011,505.010,369.014,001.09,558.011,573.011,553.016,528.010,415.0
EBITDA1,325.093.01,848.01,101.01,352.01,956.03,191.01,396.02,001.02,317.03,558.01,450.0
EBIT668.0-583.01,054.0441.0655.01,268.02,486.0665.01,230.01,490.02,643.0618.0
Profit
PBT before Exceptional Items-98.0-1,623.090.0-374.0-304.0708.01,679.0-199.0696.0808.01,985.0-17.0
+ Exceptional Items-87.0-17.0-105.0-49.0-8.0-76.0-275.0-9.0142.0-56.0-16.0-9.0
Pretax Income-185.0-1,640.0-15.0-423.0-312.0632.01,404.0-208.0838.0752.01,969.0-26.0
+ Current Tax290.085.0173.0189.0258.0-424.0272.0205.0363.0187.0488.0309.0
+ Deferred Tax-386.0-144.0-63.0-117.0-120.0-75.026.0-219.0-191.0-6.0110.0-345.0
Tax Expense-96.0-59.0110.072.0138.0-499.0298.0-14.0172.0181.0598.0-36.0
+ Share of Associates & JVs-204.0-26.045.0-32.0-135.0-278.0-27.018.0-54.0-81.0-77.0-83.0
Net Income-293.0-1,607.0-80.0-527.0-585.0853.01,079.0-176.0612.0490.01,294.0-73.0
+ Net Income — Continuing Ops-89.0-1,581.0-125.0-495.0-450.01,131.01,106.0-194.0666.0571.01,371.010.0
+ Other Comprehensive Income-112.0581.0-299.0-438.0600.0-567.0447.0434.01,016.0412.01,711.0-7.0
Total Comprehensive Income-405.0-1,026.0-379.0-965.015.0286.01,526.0258.01,628.0902.03,005.0-80.0
Net Income to Common-189.0-1,217.040.0-384.0-443.0828.0896.0-88.0553.0396.01,061.010.0
Minority Interest-104.0-390.0-120.0-143.0-142.025.0183.0-88.059.094.0233.0-83.0
Per Share
Basic EPS-2.54-17.110.52-6.02-5.909.9811.42-1.986.754.6912.570.12
Diluted EPS-2.54-17.110.52-6.02-5.909.7011.15-1.986.744.6912.570.12
Other Comprehensive Income — detail
+ Other Comprehensive Income447.0434.01,016.0412.01,711.0-7.0
+ Items NOT to be Reclassified to P&L-12.018.0-9.0-14.012.030.07.021.025.0-23.08.0
+ Tax on Items NOT to be Reclassified-1.0-2.00.01.04.00.0
+ Tax on Items NOT to be Reclassified — alt tag-11.00.02.0-2.00.01.0
+ Items to be Reclassified to P&L-123.0593.0-315.0-431.0614.0-578.0416.0425.0995.0388.01,738.0-15.0
Comprehensive Income — Owners of Parent-275.0-748.0-197.0-733.056.0-247.01,329.0195.01,306.0716.01,398.02.0
Comprehensive Income — Non-controlling Interests-130.0-278.0-182.0-232.0-41.0-320.0197.063.0322.0186.0313.0-82.0
Per Share — as-filed variants
Basic EPS — Continuing Operations-2.54-17.110.52-6.02-5.909.9811.42-1.986.754.6912.570.12
Diluted EPS — Continuing Operations-2.54-17.110.52-6.02-5.909.7011.15-1.986.744.6912.570.12
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit4,938.03,564.05,069.04,547.05,267.05,578.07,022.05,047.06,266.06,423.08,212.05,866.0
Gross Margin %48.5536.0536.0150.1547.4951.1445.0954.7652.1352.3544.7957.62
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-98.0-1,623.090.0-374.0-304.0708.01,679.0-199.0696.0808.01,985.0-17.0
− Exceptional Items (reconciliation)-87.0-17.0-105.0-49.0-8.0-76.0-275.0-9.0142.0-56.0-16.0-9.0
Net Income Adj (tax-effected)-251.1-1,590.625.0-478.0-577.0929.01,295.6-167.6499.1532.51,305.1-69.4
EPS Adj-2.18-16.94-0.16-5.46-5.8210.8713.71-1.895.515.1012.680.11
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.002.002.002.002.002.002.00
Filed Debt Equity0.010.010.010.010.010.010.010.000.00
Filed Dscr0.01-0.010.010.010.010.020.010.000.00
Filed Iscr0.01-0.010.010.010.010.020.030.000.00
Paid Up Equity Capital150.0150.0150.0150.0150.0155.0159.0159.0169.0169.0169.0169.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.